Study Finds CB-CAPs Could Be a Biomarker for Probable Lupus

Vanessa Caceres is a medical writer in Bradenton, Florida.

Study Disclosures

The study was supported by Exagen.

References

Ramsey-Goldman R, Alexander RV, Massarotti EM, et al. Complement activation in patients with probable systemic lupus erythematosus and ability to predict progression to American College of Rheumatology-classified systemic lupus erythematosus. Arthritis Rheumatol. 2020 Jan;72(1):78–88.
Mosca M, Costenbader KH, Johnson SR, et al. Brief report: How do patients with newly diagnosed systemic lupus erythematosus present? A multicenter cohort of early systemic lupus erythematosus to inform the development of new classification criteria. Arthritis Rheumatol. 2019 Jan;71(1):91–98.

A recently developed frailty index may be a valuable way to quantify vulnerability in patients with systemic lupus erythematosus (SLE), according to a study published in Arthritis & Rheumatology.1 When evaluating SLE, physicians consider a patient’s disease activity, organ damage and health-related quality of life. The Systemic Lupus International Collaborating Clinics (SLICC)/ACR Damage Index (SDI)…

Two case studies demonstrate the difficulty, delay in recognizing this rare autoinflammatory disease

Dr. Pisetsky’s picks for the top research in lupus presented at ACR Convergence 2021.

Progress toward targeted therapy

Study Disclosures

References

A New Frailty Index Aids Lupus Assessment

Cryopyrin-Associated Periodic Syndromes: Difficult to Recognize, Diagnose, Treat

Top 12: Research in Systemic Lupus Erythematosus at a Glance

T Cells in Systemic Lupus Erythematosus

Study Disclosures

References

Related Articles